Hyperprolaktin盲mie

详细信息    查看全文

• 作者：Prof. Dr. F. Nawroth
• 关键词：Makroprolaktin盲mie ; Prolaktin ; Prolaktinom ; Sterilit盲t ; Hypothyreose ; Macroprolactinemia ; Prolactin ; Prolactinoma ; Sterility ; Hypothyroidism
• 刊名：Der Gyn?kologe
• 出版年：2015
• 出版时间：May 2015
• 年：2015
• 卷：48
• 期：5
• 页码：383-393
• 全文大小：872 KB
• 参考文献：1.Riddle O, Bates RW, Dykshorn SW (1933) The preparation, identification and assay of prolactin 鈥?a hormone of the anterior pituitary. Am J Physiol 105:191鈥?16
  2.Goffin V, Binart N, Touraine P, Kelly PA (2002) Prolactin. The new biology of an old hormone. Annu Rev Physiol 64:47鈥?7View Article PubMed
  3.Goffin V, Shiverick KT, Kelly PA, Martial JA (1996) Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen and related proteins in mammals. Endocr Rev 17:385鈥?10PubMed
  4.Yazigi RA, Quintero CH, Salameh WA (1997) Prolactin disorders. Fertil Steril 67:215鈥?25View Article PubMed
  5.Jacobs LS, Snyder PJ, Wilbur JF et al (1971) Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man. J Clin Endocrinol Metab 33:996鈥?98View Article PubMed
  6.Clemens JA, Roush ME, Fuller RW (1978) Evidence that serotonin neurons stimulate secretion of prolactin releasing factor. Life Sci 22:2209鈥?213View Article PubMed
  7.Maslar IA, Riddick DH (1979) Prolactin production by human endometrium during the normal menstrual cycle. Am J Obstet Gynecol 135:751鈥?54PubMed
  8.Ben-Jonathan N, Mershon JL, Allen DL et al (1996) Extrapituitary prolactin: distribution, regulation and clinical aspects. Endocr Rev 17:639鈥?69PubMed
  9.McNatty KP, Sawers RS, McNeilly AS (1974) A possible role for prolactin in control of steroid secretion by the Graafian follicle. Nature 250:653鈥?55View Article PubMed
  10.Phelps JY, Bugg EM, Shamblott MJ et al (2003) Prolactin gene expression in human ovarian follicular cells. Fertil Steril 79:182鈥?85View Article PubMed
  11.Golander A, Hurley T, Barret J et al (1978) Prolactin synthesis by human chorion-decidual tissue: a possible source of prolactin in the amniotic fluid. Science 202:311鈥?13View Article PubMed
  12.Sinha YN (1995) Structural variants of prolactin: occurrence and physiological significance. Endocr Rev 16:354鈥?96View Article PubMed
  13.Posner BI, Kelly PA, Shiu RP, Friesen HG (1974) Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization. Endocrinology 95:521鈥?31View Article PubMed
  14.Arden KC, Boutin JM, Djiane J et al (1990) The receptors for prolactin and growth hormone are localized in the same region of human chromosome 5. Cytogenet Cell Genet 53:161鈥?65View Article PubMed
  15.Astwood EB (1941) The regulation of corpus luteum function by hypophysial luteotrophin. Endocrinology 29:309鈥?19View Article
  16.Bole-Feysot C, Goffin V, Edery M et al (1998) Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19:225鈥?68View Article PubMed
  17.Raber W, Gessl A, Nowotny P, Vierhapper H (2003) Hyperprolactinaemia in hypothyroidism: clinical significance and impact of TSH normalization. Clin Endocrinol (Oxf) 58:185鈥?91
  18.Schlechte J, Dolan K, Sherman B et al (1989) The natural history of untreated hyperprolactinemia: a prospective analysis. J Clin Endocrinol Metab 68:412鈥?18View Article PubMed
  19.Verhelst J, Abs R (2003) Hyperprolactinemia: pathophysiology and management. Treat Endocrinol 2:23鈥?2View Article PubMed
  20.Nawroth F (2005) Hyperprolactinemia and the regular menstrual cycle in asymptomatic women 鈥?should it be treated during therapy of infertility? Reprod Biomed Online 11:581鈥?88View Article PubMed
  21.Velasquez EV, Trigo RV, Creus S et al (2006) Pituitary-ovarian axis during lactational amenorrhoea. I. Longitudinal assessment of follicular growth, gonadotrophins, sex steroids and inhibin levels before and after recovery of menstrual cyclicity. Hum Reprod 21:909鈥?15View Article PubMed
  22.Velasquez EV, Creus S, Trigo RV et al (2006) Pituitary-ovarian axis during lactational amenorrhoea. II. Longitudinal assessment of serum FSH polymorphism before and after recovery of menstrual cycles. Hum Reprod 21:916鈥?23View Article PubMed
  23.Naliato EC, Violante AH, Caldas D et al (2008) Bone density in women with prolactinoma treated with dopamine agonists. Pituitary 11:21鈥?8View Article PubMed
  24.Vartej P, Poiana C, Vartej I (2001) Effects of hyperprolactinemia on osteoporotic fracture risk in premenopausal women. Gynecol Endocrinol 15:43鈥?7View Article PubMed
  25.Ono M, Miki N, Amano K et al (2010) Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. J Clin Endocrinol Metab 95:2672鈥?679View Article PubMed
  26.Nawroth F, Ludwig M (2007) Persistierende Hyperprolaktin盲mie ohne Zyklusst枚rungen. Frauenarzt 48:454鈥?59
  27.Molitch ME, Russell EJ (1990) The pituitary 鈥瀒ncidentaloma鈥? Ann Intern Med 112:925鈥?31View Article PubMed
  28.Barlier A, Jaquet P (2006) Quinagolide 鈥?a valuable treatment option for hyperprolactinaemia. Eur J Endocrinol 154:187鈥?95View Article PubMed
  29.Schade R, Andersohn F, Suissa S et al (2007) Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 356:29鈥?8View Article PubMed
  30.Zanettini R, Antonini A, Gatto G et al (2007) Valvular heart disease and the use of dopamine agonists for Parkinson鈥檚 disease. N Engl J Med 356:39鈥?6View Article PubMed
  31.Tan T, Cabrita IZ, Hensman D et al (2010) Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia. Clin Endocrinol (Oxf) 73:369鈥?74
  32.Auriemma RS, Pivonello R, Perone Y et al (2013) Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas. Eur J Endocrinol 169:359鈥?66View Article PubMed
  33.Dekkers OM, Lagro J, Burman P et al (2010) Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis. J Clin Endocrinol Metab 95:43鈥?1View Article PubMed
  34.Colao A, Di Sarno A, Cappabianca P et al (2003) Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N Engl J Med 349:2023鈥?033View Article PubMed
  35.Auriemma RS, Perone Y, Di Sarno A et al (2013) Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation. J Clin Endocrinol Metab 98:372鈥?79View Article PubMed
  36.Melmed S, Casanueva FF, Hoffman AR et al (2011) Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:273鈥?88View Article PubMed
  
• 作者单位：Prof. Dr. F. Nawroth (1)
  
  1. Facharzt-Zentrum f眉r Kinderwunsch, Pr盲natale Medizin, Endokrinologie und Osteologie, amedes experts Hamburg, M枚nckebergstr. 10 (Barkhof), 20095, Hamburg, Deutschland
  
• 刊物主题：Gynecology; Obstetrics/Perinatology; Endocrinology;
• 出版者：Springer Berlin Heidelberg
• ISSN：1433-0393

文摘

Prolactin is an important hormone in the female menstrual cycle but it often leads to misinterpretation followed by sometimes questionable diagnostic and therapeutic decisions. Uncertainty often exists concerning the necessity for imaging procedures in the primary diagnostics and during the follow-up of increased serum prolactin levels, the procedure in patients with cycle irregularities, sterility, during pregnancy and lactation. The article deals with these problems, gives a summary of practically relevant knowledge and presents possible flow sheets for routine work.